🔎 Trials Near Me

Home › Cancer (all types) › NCT01885299

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

RecruitingObservational study

Multi-Institution Registry of SRS/SBRT Procedures

Who can join

All ages · All sexes

Full eligibility criteria
Inclusion Criteria:

* Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
* Willingness to sign an Informed Consent Document or verbally agree to participation

Exclusion Criteria:

* There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included

About the study

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

What is being tested

Sponsor: The Radiosurgery Society · Participants: 50,000 · Started: 2012-03

Contact the study team

Official record on ClinicalTrials.gov — NCT01885299

Locations in the U.S.

FloridaSylvester Comprehensive Cancer Center, University of Miami, Miami
MichiganHenry Ford Health System, Detroit

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.